Times Square Capital Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Times Square Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$18.62 - $24.51 $10.4 Million - $13.6 Million	-556,290 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$21.11 - $28.48 $3.88 Million - $5.23 Million	-183,760 Reduced 24.83%	556,290 $12.2 Million
Q1 2019 May 10, 2019	SELL	$24.76 - $31.66 $365,606 - $467,491	-14,766 Reduced 1.96%	740,050 $20.3 Million
Q4 2018 Feb 14, 2019	BUY	$24.11 - $31.34 $2.2 Million - $2.86 Million	91,231 Added 13.75%	754,816 $20.3 Million
Q3 2018 Nov 14, 2018	BUY	$26.99 - $35.85 $2.03 Million - $2.7 Million	75,300 Added 12.8%	663,585 $0
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $10 Million - $20.7 Million	588,285 New	588,285 $18.4 Million

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.